Skip to main content
OBIO
NASDAQ Life Sciences

Orchestra BioMed Launches Unpriced Stock Offering to Fund Pivotal Trials

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$4.7
Mkt Cap
$337.79M
52W Low
$3.46
52W High
$6.5
52W Position info
36% above low
Off High info
28% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

OBIO sits 36% above its 52-week low of $3.46.

Summary

Orchestra BioMed kicked off an underwritten public offering of common stock with no size or price disclosed, and will grant underwriters a 30-day option for up to 15% more shares. Proceeds go to the AVIM Therapy/BACKBEAT pivotal trial and the Virtue SAB program including the Virtue Trial, plus working capital. This is a small-cap (roughly $338M) that burned $23.8M in Q2 on $88K of revenue, so an equity raise was the obvious next step after the $40.9M financing that pushed runway into late 2027. Unpriced overnight deals typically price at a discount to the $4.70 last sale, and dilution is the immediate issue for holders. Piper Sandler and TD Cowen are joint bookrunners with BTIG. Medtronic (MDT) is only the AVIM collaboration partner here and is not a party to the offering.

At the time of this announcement, OBIO was trading at $4.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $337.8M. The 52-week trading range was $3.46 to $6.50. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

OBIO - Latest Insights

OBIO
Nov 05, 2026, 10:43 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $5.00 info
Change: $0 (0%) info
Market Cap: $337.79M info
OBIO
Nov 05, 2026, 4:01 PM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $5.56
Real-time Price: $5.00 info
Change: -$0.560 (-10%) info
Market Cap: $337.79M info
OBIO
Oct 01, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $6.08
Real-time Price: $5.00 info
Change: -$1.08 (-18%) info
Market Cap: $337.79M info
OBIO
Aug 10, 2026, 4:20 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.46
Real-time Price: $5.00 info
Change: +$0.540 (+12%) info
Market Cap: $337.79M info
OBIO
Aug 10, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.46
Real-time Price: $5.00 info
Change: +$0.540 (+12%) info
Market Cap: $337.79M info